4//SEC Filing
Hansard Adam 4
Accession 0001209191-22-002968
CIK 0001697532other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 6:44 PM ET
Size
7.9 KB
Accession
0001209191-22-002968
Insider Transaction Report
Form 4
Hansard Adam
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-01-07+31,700→ 96,970 total - Award
Employee Stock Option (Right to Buy)
2022-01-07+21,100→ 21,100 totalExercise: $4.17Exp: 2032-01-07→ Common Stock (21,100 underlying)
Footnotes (2)
- [F1]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 7, 2023, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F2]Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001805556
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 6:44 PM ET
- Size
- 7.9 KB